APA (7th ed.) Citation

Zulbaran‐Rojas, A., Lin, H., Shi, Q., Williams, L. A., George, B., Garcia‐Manero, G., . . . Kantarjian, H. (2018). A prospective analysis of symptom burden for patients with chronic myeloid leukemia in chronic phase treated with frontline second‐ and third‐generation tyrosine kinase inhibitors. Cancer Medicine, 7(11), 5457. https://doi.org/10.1002/cam4.1808

Chicago Style (17th ed.) Citation

Zulbaran‐Rojas, Alejandro, et al. "A Prospective Analysis of Symptom Burden for Patients with Chronic Myeloid Leukemia in Chronic Phase Treated with Frontline Second‐ and Third‐generation Tyrosine Kinase Inhibitors." Cancer Medicine 7, no. 11 (2018): 5457. https://doi.org/10.1002/cam4.1808.

MLA (9th ed.) Citation

Zulbaran‐Rojas, Alejandro, et al. "A Prospective Analysis of Symptom Burden for Patients with Chronic Myeloid Leukemia in Chronic Phase Treated with Frontline Second‐ and Third‐generation Tyrosine Kinase Inhibitors." Cancer Medicine, vol. 7, no. 11, 2018, p. 5457, https://doi.org/10.1002/cam4.1808.